S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

MRSN Mersana Therapeutics Inc

3.37

0.00 (0.00%)

Pre Market

Last Updated: 03:00:00

Delayed by 15 minutes

Mersana Therapeutics GAAP EPS of -$0.68 misses by $0.01, revenue of $0.01M in-line

To read the full story on Seeking Alpha, click here.

Mersana Therapeutics (NASDAQ:MRSN)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Mersana Therapeutics Charts.

Mersana Therapeutics (NASDAQ:MRSN)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Mersana Therapeutics Charts.

Mersana Therapeutics Inc News

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Thursday 4 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form POSASR - Post-effective Amendment to an automatic shelf registration statement
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.

Mersana Therapeutics to Present at Upcoming Investor Conferences
Tuesday 27 February 2024 (2 months ago) • GlobeNewswire Inc.

Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024
Wednesday 21 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Friday 16 February 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)

More Mersana Therapeutics Inc News Articles

Global Developments (PK)

FBEC Worldwide (PK)

Mullen Automotive

Atacama Resources (PK)

NaturalShrimp (QB)

NioCorp Developments

Federal Home Loan Mortgage (QB)

Branded Legacy (PK)

MicroCloud Hologram

International Star (PK)

Fannie Mae (QB)

Tonner One World (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions